Serum IL‐35 levels is a new candidate biomarker of cancer‐related cachexia in stage IV non‐small cell lung cancer

BACKGROUND: Cancer‐related cachexia is a major cause of treatment resistance and poor prognosis, which is characterized by anorexia and skeletal muscle depletion. To date, there have been no reports on the relationship between IL‐35 and cancer‐related cachexia in patients with stage IV non‐small cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zengxun, Zhu, Lei, Zheng, Han, Jiang, Wenna, Wang, Yifei, Jiang, Zhansheng, Xu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888146/
https://www.ncbi.nlm.nih.gov/pubmed/35142058
http://dx.doi.org/10.1111/1759-7714.14307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888146/
https://www.ncbi.nlm.nih.gov/pubmed/35142058
http://dx.doi.org/10.1111/1759-7714.14307

Ejemplares similares